Brief: Chimeric Therapeutics Ltd Says HY Loss For The Period A$11.7 Mln Versus Loss Of A$9.7 Mln
Feb 28 (Reuters) - Chimeric Therapeutics Ltd CHM.AX :
* HY LOSS FOR THE PERIOD A$11.7 MILLION VERSUS LOSS OF A$9.7
MILLION
Source text for Eikon: ID:nASXbXR3N5
Further company coverage: CHM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial